Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-18 Purchase | 2024-12-19 10:23 am | PALVELLA THERAPEUTICS INC. | PVLA | JENKINS GEORGE M Director | 4,000 | $12.93 | $51,720 | 191,697 (Indirect Direct) | View |
| 2024-08-09 Purchase | 2024-08-12 6:48 pm | PIERIS PHARMACEUTICALS INC. | PIRS | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner | 6,000 | $15.39 | $92,326 | 15,067 (Indirect) | View |
| 2023-05-25 Purchase | 2023-05-30 4:21 pm | PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director | 10,000 | $0.85 | $8,500 | 20,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-13 Option Award | 2024-12-17 8:46 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | HERON ELAINE J Director | 24,700 | $0 | 24,700 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:45 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | Wessel Tadd S. Director | 24,700 | $0 | 24,700 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:44 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | Davis Todd C Director | 24,700 | $0 | 24,700 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:44 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | Martini Jeffrey S Chief Scientific Officer | 126,416 | $0 | 126,416 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:43 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | Goin Kathleen Chief Operating Officer | 27,843 | $0 | 27,843 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:43 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | Korenberg Matthew E CFO, Treasurer | 167,100 | $0 | 167,100 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:42 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | JENKINS GEORGE M Director | 24,700 | $0 | 24,700 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:41 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | Kaupinen Wes President and CEO 10% Owner | 417,806 | $0 | 417,806 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:40 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | KIRITSY CHRISTOPHER P Director | 24,700 | $0 | 24,700 (Direct) | View |
| 2024-12-13 Other | 2024-12-17 5:44 pm | N/A N/A | PALVELLA THERAPEUTICS INC. | PVLA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 438,929 | $0 | 493,205 (Direct) | View |
Ownership | 2024-12-16 7:43 pm | N/A N/A | PALVELLA THERAPEUTICS INC. | PVLA | Kaupinen Wes President & CEO 10% Owner | 0 | $0 | 1,708,650 (Direct) | View |
Ownership | 2024-12-16 7:43 pm | N/A 2029-10-29 | PALVELLA THERAPEUTICS INC. | PVLA | Goin Kathleen Chief Operating Officer | 0 | $0 | 177,608 (Direct) | View |
Ownership | 2024-12-16 7:42 pm | N/A 2030-10-11 | PALVELLA THERAPEUTICS INC. | PVLA | Martini Jeffrey S Chief Scientific Officer | 0 | $0 | 80,913 (Direct) | View |
Ownership | 2024-12-16 7:41 pm | N/A N/A | PALVELLA THERAPEUTICS INC. | PVLA | JENKINS GEORGE M Director | 0 | $0 | 206,122 (Direct) | View |
Ownership | 2024-12-16 7:41 pm | N/A N/A | PALVELLA THERAPEUTICS INC. | PVLA | Davis Todd C Director | 0 | $0 | 128,651 (Direct) | View |
Ownership | 2024-12-16 7:40 pm | N/A N/A | PALVELLA THERAPEUTICS INC. | PVLA | HERON ELAINE J Director | 0 | $0 | 55,933 (Direct) | View |
| 2024-12-12 Disposition | 2024-12-12 4:16 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | GERAGHTY JAMES A Director | 1 | $0.01 | 0 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-09 07:32 am | N/A 2034-12-02 | PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director | 500 | $0 | 500 (Direct) | View |
Ownership | 2024-11-18 4:16 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | Dellora Investments LP 10% Owner | 0 | $0 | 141,079 (Indirect) | View |
Ownership | 2024-07-31 7:26 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner | 0 | $0 | 138,641 (Indirect) | View |
| 2023-06-21 Option Award | 2023-06-23 4:47 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Barbier Ann Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:46 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | GERAGHTY JAMES A Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:46 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Kiener Peter A Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:46 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | KIRITSY CHRISTOPHER P Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:45 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Richman Michael Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:45 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Said Maya R. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:45 pm | N/A 2033-06-21 | PIERIS PHARMACEUTICALS INC. | PIRS | Sherman Matthew L Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-05-22 5:00 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 39,154,557 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:39 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Bures Thomas Chief Financial Officer | 249,080 | $0 | 249,080 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:35 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Kaufmann Hitto Chief Scientific Officer | 249,080 | $0 | 249,080 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:31 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Mousa Ahmed Chief Business Officer | 249,080 | $0 | 249,080 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:23 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 249,080 | $0 | 249,080 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:09 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Yoder Stephen S. Chief Executive Officer | 634,021 | $0 | 634,021 (Direct) | View |